The first important event of the year 2018 for NATIVITA Company was the receipt of the GMP Compliance Certificate by the injectable drugs’ production site of the medicine production facility, ensuring a consistently high quality of the manufactured medicinal products. For the majority of international companies, the availability of a GMP Compliance Certificate is a prerequisite for cooperation and procurement.
According to Olga Nevinskaya, Deputy CEO of NATIVITA JLLC for QA, the GMP Compliance Certificate makes NATIVITA an enterprise with a reliable certified pharmaceutical quality system, offering new opportunities for technology transfer and production of the most advanced expensive drugs.
